A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels

Journal of Vascular Research

Volumn 37, Issue 6, 2000, Pages 443-448

  Renner, Wilfried ^a,b   Kotschan, Sabine ^a   Hoffmann, Christine ^a   Obermayer Pietsch, Barbara ^a   Pilger, Ernst ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Angiogenesis; Gene mutation; Vascular endothelial growth factor

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 4; UNCLASSIFIED DRUG; VASCULOTROPIN;

3' UNTRANSLATED REGION; ADULT; ANGIOGENESIS; ARTICLE; BINDING SITE; BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; ALLELES; BINDING SITES; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENES; GENOTYPE; HUMANS; LYMPHOKINES; MALE; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSCRIPTION FACTORS; VARIATION (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034509524     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054076     Document Type: Article

References (31)

1. Vascular endothelial growth factor is a secreted angiogenic mitogen
2. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
3. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
4. Vascular permeability factor: A tumor derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
5. Vascular permeability factor, an endothelial cell mitogen related to PDGF
6. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
7. Angiogenesis: A dynamic balance of stimulators and inhibitors
8. Oncogenic transformation hypoxia synergistically act to modulate vascular endothelial growth factor expression
9. Common proteins bind mRNAs encoding erythropoietin, tyrosine hydroxylase, and vascular endothelial growth factor
10. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
11. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
12. Abnormal blood vessel development lethality in embryos lacking a single VEGF allele
13. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease
14. In vitro release of vascular endothelial growth factor during platelet aggregation
15. Simultaneous in vivo quantitation of vascular endothelial growth factor mRNA splice variants
16. C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease
17. MatInd and MatInspector - New fast and versatile tools for detection of consensus matches in nucleotide sequence data
18. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: Survival effect of vascular endothelial growth factor on circulating unanchored endothelial cells
19. Vascular endothelial growth factor in acute Kawasaki disease
20. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer
21. Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer
22. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor
23. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity
24. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro
25. Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription
26. Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: Association with changes in ovarian uterine Doppler blood flow
27. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
28. Angiogenesis in embryos and ischemic diseases
29. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing
30. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
31. Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF)